Impact of bariatric and metabolic surgery on nonalcoholic fatty liver disease

doi:10.16139/j.1007-9610.2020.05.004

Abstract

CLC Number:

R589.2

HUA Rong, YAO Qiyuan. Impact of bariatric and metabolic surgery on nonalcoholic fatty liver disease[J]. Journal of Surgery Concepts & Practice, 2020, 25(05): 373-377.

References 42

[1]	NCD Risk Factor Collaboration(NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants[J]. Lancet, 2016, 387(10026):1377-1396.
[2]	Chalasani N, Younossi Z, Lavine J, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association[J]. Hepatology, 2012, 55(6):2005-2023. doi: 10.1002/hep.25762 pmid: 22488764
[3]	Kleiner DE, Brunt EM, van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease[J]. Hepatology, 2005, 41(6):1313-1321. doi: 10.1002/hep.20701 pmid: 15915461
[4]	Borges-Canha M, Neves JS, Mendonça F, et al. The impact of bariatric surgery on hepatic function and predictors of liver steatosis and fibrosis[J]. Obes Surg, 2020, 30(8):2935-2941. doi: 10.1007/s11695-020-04622-0 pmid: 32306299
[5]	Younossi Z, Koenig A, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology, 2016, 64(1):73-84. doi: 10.1002/hep.28431 pmid: 26707365
[6]	Mummadi RR, Kasturi KS, Chennareddygari S, et al. Effect of bariatric surgery on nonalcoholic fatty liver di-sease: a systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2008, 6(12):1396-1402.
[7]	Udelsman BV, Corey KE, Lindvall C, et al. Risk factors and prevalence of liver disease in review of 2557 routine liver biopsies performed during bariatric surgery[J]. Surg Obes Relat Dis, 2019, 15(6):843-849. doi: S1550-7289(19)30050-4 pmid: 31014948
[8]	Portillo Sanchez P, Bril F, Maximos M, et al. High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels[J]. J Clin Endocrinol Metab, 2015, 100(6):2231-2238. doi: 10.1210/jc.2015-1966 pmid: 25885947
[9]	Agopian VG, Kaldas FM, Hong JC. Live transplantation for nonalcoholic steatohepatitis: the new epidemic[J]. Ann Surg, 2012, 256(4):624-633. doi: 10.1097/SLA.0b013e31826b4b7e pmid: 22964732
[10]	Salman MA, Mikhail HMS, Nafea MA, et al. Impact of laparoscopic sleeve gastrectomy on fibrosis stage in patients with child-A NASH-related cirrhosis[J]. Surg Endosc, 2020. doi: 10.1007/s00464-020-07498-4. doi: 10.1007/s00464-020-07498-4 URL
[11]	Younus H, Sharma A, Miquel R, et al. Bariatric surgery in cirrhotic patients: is it safe?[J]. Obes Surg, 2020, 30(4):1241-1248. doi: 10.1007/s11695-019-04214-7 pmid: 31853866
[12]	Lazzati A, Iannelli A, Schneck AS, et al. Bariatric surgery and liver transplantation: a systematic review a new frontier for bariatric surgery[J]. Obes Surg, 2015, 25(1):134-142. doi: 10.1007/s11695-014-1430-8 pmid: 25337867
[13]	Ayloo S, Gussa C, Ram S, et al. Minimally invasive sleeve gastrectomy as a surgical treatment for nonalcoholic fatty liver disease in liver transplant recipients[J]. Transplant Proc, 2020, 52(1):276-283
[14]	Gasteyger C, Larsen TM, Vercruysse F, et al. Effect of a dietary induced weight loss on liver enzymes in obese subjects[J]. Am J Clin Nutr, 2008, 87(5):1141-1147.
[15]	Baltasar A, Serra C, Perez N, et al. Clinical hepatic impairment after the duodenal switch[J]. Obes Surg, 2004, 14(1):77-83. pmid: 14980038
[16]	Requarth JA, Burchard KW, Colacchio TA, et al. Long-term morbidity following jejunoileal bypass. The continuing potential need for surgical reversal[J]. Arch Surg, 1995, 130(3):318-325.
[17]	Eilenberg M, Langer FB, Beer A, et al. Significant liver-related morbidity after bariatric surgery and its reversal-a case series[J]. Obes Surg, 2018, 28(3):812-819.
[18]	Sugerman HJ, Kellum JM, DeMaria EJ. Conversion of proximal to distal gastric bypass for failed gastric bypass for superobesity[J]. J Gastrointest Surg, 1997, 1(6):517-524, discussion 524-526.
[19]	Baldwin D, Chennakesavalu M, Gangemi A. Systematic review and meta-analysis of Roux-en-Y gastric bypass against laparoscopic sleeve gastrectomy for amelioration of NAFLD using four criteria[J]. Surg Obes Relat Dis, 2019, 15(12):2123-2130. doi: S1550-7289(19)30997-9 pmid: 31711944
[20]	Fakhry TK, Mhaskar R, Schwitalla T, et al. Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis[J]. Surg Obes Relat Dis, 2019, 15(3):502-511.
[21]	Kwak M, Mehaffey JH, Hawkins RB, et al. Bariatric surgery is associated with reduction in non-alcoholic steatohepatitis and hepatocellular carcinoma: a propensity matched analysis[J]. Am J Surg, 2020, 219(3):504-507.
[22]	Wirth KM, Sheka AC, Kizy S, et al. Bariatric surgery is associated with decreased progression of nonalcoholic fatty liver disease to cirrhosis: a retrospective cohort analysis[J]. Ann Surg, 2020, 272(1):32-39.
[23]	Lambert JE, Ramos-Roman MA, Browning JD, et al. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease[J]. Gastroenterology, 2014, 146(3):726-735.
[24]	Tannapfel A, Denk H, Dienes HP, et al. Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease[J]. Virchows Arch, 2011, 458(5):511-523.
[25]	Jacome-Sosa MM, Parks EJ. Fatty acid sources and their fluxes as they contribute to plasma triglyceride concentrations and fatty liver in humans[J]. Curr Opin Lipidol, 2014, 25(3):213-220. doi: 10.1097/MOL.0000000000000080 pmid: 24785962
[26]	Day CP, James OF. Steatohepatitis: a tale of two “hits”[J]. Gastroenterology, 1998, 114(4):842-845. pmid: 9547102
[27]	Kozlitina J, Smagris E, Stender S, et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease[J]. Nat Genet, 2014, 46(4):352-356. doi: 10.1038/ng.2901 pmid: 24531328
[28]	Sookoian S, Rosselli MS, Gemma C, et al. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter[J]. Hepatology, 2010, 52(6):1992-2000. doi: 10.1002/hep.23927 pmid: 20890895
[29]	Luedde T, Kaplowitz N, Schwabe RF. Cell death and cell death responses in liver disease: mechanisms and clinical relevance[J]. Gastroenterology, 2014, 147(4):765-783.e4. doi: 10.1053/j.gastro.2014.07.018 pmid: 25046161
[30]	Cusi K. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis[J]. Clin Liver Dis, 2009, 13(4):545-563.
[31]	Seki E, de Minicis S, Osterreicher CH, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis[J]. Nat Med, 2007, 13(11):1324-1332.
[32]	Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes-5-year outcomes[J]. N Engl J Med, 2017, 376(7):641-651.
[33]	Leonetti F, Capoccia D, Coccia F, et al. Obesity, type 2 diabetes mellitus, and other comorbidities: a prospective cohort study of laparoscopic sleeve gastrectomy vs. medical treatment[J]. Arch Surg, 2012, 147(8):694-700. pmid: 22508671
[34]	Hua R, Wang GZ, Shen QW, et al. Sleeve gastrectomy ameliorated HFD-induced non-alcoholic fatty liver di-sease and upregulated the nicotinamide adenine dinucleotide +/Sirtuin-1 pathway in mice[J]. Asian J Surg,2020-07-22.doi: 10.1016/j.asjsur.2020.05.030. doi: 10.1016/j.asjsur.2020.05.030 URL
[35]	Jørgensen NB, Jacobsen SH, Dirksen C, et al. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with type 2 diabetes and normal glucose tolerance[J]. Am J Physiol Endocrinol Metab, 2012, 303(1):E122-E131.
[36]	Svegliati-Baroni G, Saccomanno S, Rychlicki C, et al. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis[J]. Liver Int, 2011, 31(9):1285-1297. doi: 10.1111/j.1478-3231.2011.02462.x pmid: 21745271
[37]	Yousseif A, Emmanuel J, Karra E, et al. Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans[J]. Obes Surg, 2014, 24(2):241-252. doi: 10.1007/s11695-013-1066-0 pmid: 23996294
[38]	Whang W, Liu Y, Kageyama S, et al. Vertical sleeve gastrectomy attenuates the progression of non-alcoholic steatohepatitis in mice on a high-fat high-cholesterol diet[J]. Obes Surg, 2019, 29(8):2420-2429.
[39]	Patti ME, Houten SM, Bianco AC, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism[J]. Obesity (Silver Spring), 2009, 17(9):1671-1677.
[40]	Nakatani H, Kasama K, Oshiro T, et al. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery[J]. Metabolism, 2009, 58(10):1400-1407.
[41]	Huang HH, Lee WJ, Chen SC, et al. Bile acid and fibroblast growth factor 19 regulation in obese diabetics, and non-alcoholic fatty liver disease after sleeve gastrectomy[J]. J Clin Med, 2019, 8(6):815-829.
[42]	Fei N, Bruneau A, Zhang X, et al. Endotoxin producers overgrowing in human gut microbiota as the causative agents for nonalcoholic fatty liver disease[J]. mBio, 2020, 11(1):e03263-19.

Impact of bariatric and metabolic surgery on nonalcoholic fatty liver disease

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 42

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	XUAN Chengjie, BIAN Dongsheng, JIANG Yongmei, CHEN Yufei, JIN Jiabin, SHI Yongmei. Effect of nutritional therapy on body composition and resting energy expenditure post bariatric surgery [J]. Journal of Surgery Concepts & Practice, 2022, 27(03): 244-248.
[2]	HU Songhao, DONG Zhiyong, WANG Cunchuan. Standardization and surgical innovation of bariatric and metabolic surgery [J]. Journal of Surgery Concepts & Practice, 2020, 25(05): 361-363.
[3]	CA Chaogiang, SUN Xulong, ZHU Shaihong. Bariatric and metabolic surgery in China: recent developments and future prospects [J]. Journal of Surgery Concepts & Practice, 2020, 25(05): 364-368.
[4]	YING Xiayang, IIN Jiabin, SHEN Baiyong. Robot-assisted surgery in bariatric and metabolic surgery: application and progress in China [J]. Journal of Surgery Concepts & Practice, 2020, 25(05): 369-372.
[5]	YANG Jianjun, SONG Zhicheng, YANG Dongchao, GU Yan. Obese patients with ventral hernia: surgical treatment and strategy [J]. Journal of Surgery Concepts & Practice, 2020, 25(05): 378-382.
[6]	ZHU Jiangfan. Strategy in treatment of weight loss failure after sleeve gastrectomy [J]. Journal of Surgery Concepts & Practice, 2020, 25(05): 383-385.
[7]	YAN Wenmao, BAI Rixing. Causes and prevention of weight regain after bariatric and metabolic surgery [J]. Journal of Surgery Concepts & Practice, 2020, 25(05): 386-390.
[8]	ZHU Xiaocheng, HOU Dongsheng. New type of bariatric and metabolic procedure: sleeve gastrectomy with transit bipartition [J]. Journal of Surgery Concepts & Practice, 2020, 25(05): 391-396.
[9]	ZHANG Chenyang, ZHANG Hongwei, HAN Xiaodong, LIU Weijie, YU Haoyong, ZHANG Pin. Comparative study on weight loss and remission of metabolic disorders after laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy [J]. Journal of Surgery Concepts & Practice, 2020, 25(05): 397-401.
[10]	LIAN Dongbo, LIU Chen, YAN Wei, DU Dexiao, GONG Ke, ZHANG Nengwei. Application of bariatric and metabolic analysis and reporting outcome system [J]. Journal of Surgery Concepts & Practice, 2020, 25(05): 402-407.
[11]	LIU Ruiping, YANG Ningli, LIN Shibo, GUAN Wei, Liang Hui. Pregnancy outcomes and perinatal complications after three types of bariatric and metabolic surgery [J]. Journal of Surgery Concepts & Practice, 2020, 25(05): 408-412.
[12]	TIAN Peirong, LIU Yang, BIAN Shibo, LI Mengyi, ZHANG Meng, LIU Jia, JIN Lan, ZHANG Zhongtao, ZHANG Peng. Effect of bariatric and metabolic surgery on anemia related parameters: a retrospective study [J]. Journal of Surgery Concepts & Practice, 2020, 25(05): 413-416.
[13]	LIU Yanyang, HUA Rong, XU Bo, SHEN Qiwei, HUANG Xianjue, YAO Qiyuan. Fresh frozen cadavers for clinical teaching of laparoscopic bariatric and metabolic surgery [J]. Journal of Surgery Concepts & Practice, 2020, 25(05): 417-421.
[14]	WU Lisheng, YU Jianwei, LI Yu, DAI Congcong. Laparoscopic sleeve gastrectomy with four ports and posterior gastric wall dissection first: a report of 122 cases [J]. Journal of Surgery Concepts & Practice, 2020, 25(05): 422-425.
[15]	CHEN Fu, LI Zhen, ZHOU Yong, WANG Yong. Bariatric and metabolic surgery in patient with obesity and respiratory failure: a report of one case [J]. Journal of Surgery Concepts & Practice, 2020, 25(05): 440-441.